{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:02:17Z","timestamp":1790359337609,"version":"4.1.0"},"reference-count":3,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/qjmed\/hcag250","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:17:31Z","timestamp":1789672651000},"source":"Crossref","is-referenced-by-count":0,"title":["Channeling by phenotype: does the obesity paradox in COPD confound the respiratory benefits attributed to GLP-1 receptor agonists?"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1594-9145","authenticated-orcid":false,"given":"Esteban","family":"Cardenas-Duran","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Hospital General Reynosa \u201cDr. Jos\u00e9 Mar\u00eda Cant\u00fa Garza\u201d , Reynosa, Tamaulipas,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6570-007X","authenticated-orcid":false,"given":"Hefziba","family":"Lorences-Noguera","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hospital General Reynosa \u201cDr. Jos\u00e9 Mar\u00eda Cant\u00fa Garza\u201d , Reynosa, Tamaulipas,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"2026092513513938000_hcag250-B1","doi-asserted-by":"crossref","first-page":"hcag217","DOI":"10.1093\/qjmed\/hcag217","article-title":"Associations between glucagon-like peptide-1 receptor agonists and respiratory outcomes in chronic obstructive pulmonary disease and diabetes","author":"Liao","year":"2026","journal-title":"QJM"},{"key":"2026092513513938000_hcag250-B2","doi-asserted-by":"crossref","first-page":"e43892","DOI":"10.1371\/journal.pone.0043892","article-title":"Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis","volume":"7","author":"Cao","year":"2012","journal-title":"PLoS One"},{"key":"2026092513513938000_hcag250-B3","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.2337\/dc24-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/qjmed\/advance-article-pdf\/doi\/10.1093\/qjmed\/hcag250\/71201273\/hcag250.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/advance-article-pdf\/doi\/10.1093\/qjmed\/hcag250\/71201273\/hcag250.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:51:44Z","timestamp":1790358704000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/advance-article\/doi\/10.1093\/qjmed\/hcag250\/8814058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":3,"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcag250","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"hcag250"}}